<DOC>
	<DOCNO>NCT01597401</DOCNO>
	<brief_summary>The purpose study assess safety , tolerability , pharmacokinetic , pharmacodynamic effect Aes-103 ( active ingredient 5-hydroxymethyl-2-furfural [ 5-HMF ] ) compare placebo subject stable sickle cell disease ( SCD ) . Safety measure monitoring adverse event ( AEs ) , electrocardiogram ( ECGs ) , vital sign , laboratory value . Pharmacokinetics Aes-103 measured time plasma , red blood cell hemolysate bind Aes-103 hemoglobin . Pharmacodynamic effect assess measure partial pressure oxygen 50 % hemoglobin saturate oxygen ( p50 ) breathe normal air , blood oxygen level ( SpO2 ) , ex-vivo antisickling effect hypoxic environment , image relate change tissue blood flow oxygen level .</brief_summary>
	<brief_title>A Single Dose Study Safety , Blood Levels Biological Effects Aes-103 Compared Placebo Subjects With Stable Sickle Cell Disease</brief_title>
	<detailed_description />
	<mesh_term>Anemia , Sickle Cell</mesh_term>
	<criteria>Be male female , age 1865 year old , inclusive Have sickle cell disease ( SCD ) ( hemoglobin SS ) without hospitalization pain crises 30 day screen SCD complication two occasion past 12 month ; subject allow concomitant usage hydroxyurea ( HU ) dosage stable 2 month screen dosage exceed product 's labeling . Have normal laboratory value define : Direct bilirubin 0.1 1.0 mg/dL Alanine transaminase ( serum glutamic pyruvic transaminase ) 6 41 IU/L Creatinine females 0.56 1.16 mg/dL male 0.77 1.19 mg/dL If female , nonpregnant nonbreastfeeding surgically sterile use acceptable method contraception throughout study 30 day study completion Have successfully complete outpatient screen visit consist medical history , physical examination , 12lead ECG , vital sign , hematology chemistry test , urinalysis , urine drug screen , pregnancy test ( female ) , hemoglobin electrophoresis , hepatitis B C screening , HIV serology ( Note : Subjects abnormal screen value may eligible result clinically significant , judged investigator medical monitor ) Be able understand provide write informed consent include signature inform consent form approve institutional review board Agree abide study schedule dietary restriction return require assessment Be willing abstain food high 5HMF ( e.g. , coffee , malt , barley , balsamic vinegar , dry fruit , caramel product ) least 3 day dose Have evidence clinically significant cardiovascular , respiratory , renal , hepatic , pulmonary , gastrointestinal , hematological , neurological , psychiatric , disease may interfere objective study safety subject , judge investigator agreement sponsor medical monitor , hospitalize past 6 month result condition Have hospitalize 14 day enrollment , reason Be currently regularly schedule transfusion Have receive transfusion within 2 week administration study drug Have take herbal preparation 2 week dose ( Note : subject allow concomitant usage HU schedule prescription drug dosage stable 2 month screen dosage exceed product 's labeling . These scheduled prescription medication continue study [ include dose ] . All medication , include overthecounter medication use accord product labeling , administer asneeded basis permit except 24 hour period dose day dose . Medications pain management allow need [ include dose . ] ) Have take investigational drug within 30 day 5 halflives screen visit , whichever long Consumed 14 alcoholic drink per week 3 drink per day point past month Have receive disulfiram 4methylpyrazole within 30 day dose Have take coughcold product contain dextrorphan dextromethorphan within 4 day dose Have positive result urine drug test ( cocaine , marijuana , opiates , amphetamine , methamphetamine , benzodiazepine , ethanol ) screen visit . However , use opiate , amphetamine , benzodiazepine allow prescribed physician . Have engage strenuous exercise within 72 hour prior dose Be consider suitable participation study reason , judge investigator Have preexist allergic adverse reaction orange juice</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Antisickling Agents</keyword>
</DOC>